STRS Ohio’s Pliant Therapeutics PLRX Stock Holding History

STRS Ohio’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$21K	–	2224
2022 Q1	$21K	Hold	3,000	–	–	﹤0.01%	2041
2021 Q4	$40K	Hold	3,000	–	–	﹤0.01%	2036
2021 Q3	$50K	Hold	3,000	–	–	﹤0.01%	2070
2021 Q2	$87K	Buy	3,000 +400	+15%	+$12.5K	﹤0.01%	2005
2021 Q1	$102K	Hold	2,600	–	–	﹤0.01%	1937
2020 Q4	$59K	Hold	2,600	–	–	﹤0.01%	1975
2020 Q3	$58K	Buy	+2,600	New	+$65K	﹤0.01%	1941

Other funds holding PLRX

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return

STRS Ohio's PLRX Position: Q2 2022 in Review

STRS Ohio sold out of Pliant Therapeutics (PLRX) in Q2 2022, closing a stake of 3,000 shares — an estimated $21K sold.

STRS Ohio first reported a position in PLRX in Q3 2020 and held it in 7 quarters. The position peaked at $102K in Q1 2021. 88 funds tracked by Wall St. Rank hold PLRX as of Q2 2022.

STRS Ohio reported no remaining Pliant Therapeutics position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 3,000 Pliant Therapeutics shares in Q2 2022, an estimated $21K.
STRS Ohio first reported a position in Pliant Therapeutics in Q3 2020 and held it in 7 quarters.
STRS Ohio's Pliant Therapeutics position peaked at $102K in Q1 2021.
88 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.